PageOverview.com
 

Vastra Malarehamnen 9 registered domain names

See 60 domain name(s) that specified Vastra Malarehamnen 9 as their possible contact address.

 
Number of websites/domains displayed: 60
Results found: 60
 

Websites discovered:

azconferencing.com
http://pageoverview.com/website-report/azconferencing.com
  • Expected expiration: January 20th in 2018
  • Creation date: January 20th in 2011
  • Renew date: January 16th in 2017
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol | Asthma & COPD Medicine
http://pageoverview.com/website-report/mysymbicort.com
Official patient Web site for SYMBICORT, a medicine for the treatment of asthma and COPD. Find information about the inhaler and side effects
  • Expected expiration: July 25th in 2017
  • Creation date: July 25th in 2006
  • Renew date: July 21st in 2016
azcollaboration.com
http://pageoverview.com/website-report/azcollaboration.com
  • Expected expiration: January 14th in 2018
  • Creation date: January 14th in 2011
  • Renew date: January 10th in 2017
Guide to Better Breathing | Breathe In & Out
http://pageoverview.com/website-report/breatheinout.com
Get your free e-book for breathing tips, exercises, and more, plus receive bonus content personalized to your needs from our added feature BREATHABLE.
  • Expected expiration: August 27th in 2017
  • Creation date: August 27th in 2015
  • Renew date: August 23rd in 2016
astrazeneca.net
http://pageoverview.com/website-report/astrazeneca.net
  • Expected expiration: December 7th in 2017
  • Creation date: December 8th in 1998
  • Renew date: December 3rd in 2016
Login page
http://pageoverview.com/website-report/azessentials.com
  • Expected expiration: June 6th in 2017
  • Creation date: June 6th in 2008
  • Renew date: June 2nd in 2016
AstraZeneca - Research-Based BioPharmaceutical Company
http://pageoverview.com/website-report/astrazeneca.com
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
  • Expected expiration: December 7th in 2017
  • Creation date: December 8th in 1998
  • Renew date: December 3rd in 2016
  • Google Analytics: 9600290-2
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol For Health Care Professionals
http://pageoverview.com/website-report/symbicorttouchpoints.com
Official HCP site for SYMBICORT, an asthma and COPD treatment, providing information on the inhaler, side effects, dosage and prescribing information.
  • Expected expiration: October 15th in 2017
  • Creation date: October 15th in 2009
  • Renew date: October 11th in 2016
呼吸希望 - 與肺癌共存
http://pageoverview.com/website-report/livingwithlungcancer.asia
「呼吸希望」是一項肺癌關注計劃,獲阿斯利康與香港肺癌學會 (HKLCSG) 聯合支持。
  • Expected expiration: February 14th in 2019
  • Creation date: February 14th in 2017
  • Renew date: February 8th in 2018
  • Google Analytics: 97238182-1
FARXIGA® (dapagliflozin) | Type 2 Diabetes Medication for Adults
http://pageoverview.com/website-report/farxiga.com
FARXIGA® (dapagliflozin) is an adult type 2 diabetes medication used with diet and exercise to improve glycemic control.
  • Expected expiration: August 27th in 2017
  • Creation date: August 27th in 2013
  • Renew date: August 23rd in 2016
High Blood Pressure Medication | TOPROL-XL
http://pageoverview.com/website-report/azhypertensionbrands.com
  • Expected expiration: November 19th in 2018
  • Creation date: November 19th in 2013
  • Renew date: November 19th in 2013
utils-astrazeneca.com
http://pageoverview.com/website-report/utils-astrazeneca.com
  • Expected expiration: November 7th in 2017
  • Creation date: November 7th in 2011
  • Renew date: February 26th in 2016
FARXIGA® (dapagliflozin) | Treatment for Type 2 Diabetes Mellitus in Adults
http://pageoverview.com/website-report/farxiga-hcp.com
FARXIGA® (dapagliflozin) is an SGLT2 inhibitor indicated for patients with type 2 diabetes mellitus. Explore the science behind FARXIGA.
  • Expected expiration: September 23rd in 2017
  • Creation date: September 23rd in 2013
  • Renew date: September 19th in 2016
PI-Central
http://pageoverview.com/website-report/azpicentral.com
  • Expected expiration: July 8th in 2017
  • Creation date: July 8th in 2014
  • Renew date: January 29th in 2016
Type 2 Diabetes Medication | BYETTA® (exenatide) injection
http://pageoverview.com/website-report/byetta.com
BYETTA is a non-insulin type 2 diabetes injection medication for adults.
  • Expected expiration: February 3rd in 2018
  • Creation date: February 3rd in 2004
  • Renew date: January 29th in 2017
Official Website for BYDUREON® (exenatide extended-release for injectable suspension)
http://pageoverview.com/website-report/bydureon.com
Learn about BYDUREON® (exenatide extended-release for injectable suspension), a non-insulin treatment option for adults with type 2 diabetes available in the BYDUREON Pen.
  • Expected expiration: November 15th in 2022
  • Creation date: November 15th in 2007
  • Renew date: January 29th in 2016
Nexium 24HR | Frequent Heartburn Protection
http://pageoverview.com/website-report/nexium24hr.com
Nexium® 24HR is here. The Purple Pill® you know and trust is available nationwide without a prescription for Frequent Heartburn.
  • Expected expiration: August 8th in 2017
  • Creation date: August 8th in 2013
  • Renew date: August 4th in 2016
BRILINTA® (ticagrelor) tablets | Health Care Professional Web site
http://pageoverview.com/website-report/brilintatouchpoints.com
  • Expected expiration: October 15th in 2017
  • Creation date: October 15th in 2009
  • Renew date: October 11th in 2016
Home
http://pageoverview.com/website-report/iressa.com
Official site of IRESSA (gefitinib), indicated in Europe for the treatment of adults with locally advanced or metastatic NSCLC with activating mutations of EGFR-TK across all lines of therapy.
  • Expected expiration: August 13th in 2017
  • Creation date: August 13th in 1999
  • Renew date: August 9th in 2016
RSV Protection | Respiratory Syncytial Virus Information
http://pageoverview.com/website-report/rsvprotection.com
Think you know about RSV Disease? Learn more about Respiratory Syncytial Virus, risk factors, and protection tips for your baby & infant.
  • Expected expiration: March 30th in 2018
  • Creation date: March 30th in 1999
  • Renew date: March 26th in 2017
Cholesterol Medicine | CRESTOR® (rosuvastatin calcium)
http://pageoverview.com/website-report/crestor.com
Information about CRESTOR® (rosuvastatin calcium), a prescription cholesterol medicine that helps lower LDL cholesterol when diet and exercise alone are not enough.
  • Expected expiration: October 26th in 2017
  • Creation date: October 27th in 1994
  • Renew date: October 22nd in 2016
iressaccf.org
http://pageoverview.com/website-report/iressaccf.org
  • Expected expiration: November 27th in 2017
  • Creation date: November 27th in 2012
  • Renew date: June 28th in 2017
Career opportunities at AstraZeneca | AstraZeneca Careers
http://pageoverview.com/website-report/astrazenecacareers.com
Interested in career opportunities with AstraZeneca? Search current pharmaceutical job openings at AstraZeneca and apply now!
  • Expected expiration: August 1st in 2017
  • Creation date: August 1st in 2000
  • Renew date: July 28th in 2016
  • Google Analytics: 53609256-2
BreathABLETM | SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol
http://pageoverview.com/website-report/mybreathable.com
BreathABLE from SYMBICORT (budesonide/formoterol fumarate dihydrate) was created to help you control and manage difficulty breathing if you have COPD.
  • Expected expiration: September 8th in 2017
  • Creation date: September 8th in 2015
  • Renew date: September 7th in 2016
BRILINTA® (ticagrelor) tablets | Heart Attack Treatment
http://pageoverview.com/website-report/brilinta.com
Read about BRILINTA® (ticagrelor) tablets, a prescription medication for heart attack treatment, or severe chest pain, also known as unstable angina.
  • Expected expiration: April 21st in 2018
  • Creation date: April 21st in 2005
  • Renew date: April 17th in 2017
COPD Treatment | TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder)
http://pageoverview.com/website-report/tudorza.com
Patient information on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with COPD.
  • Expected expiration: March 4th in 2020
  • Creation date: March 4th in 2011
  • Renew date: March 31st in 2016
fit2mecoach.com
http://pageoverview.com/website-report/fit2mecoach.com
  • Expected expiration: April 1st in 2019
  • Creation date: April 1st in 2014
  • Renew date: September 5th in 2014
astra.com
http://pageoverview.com/website-report/astra.com
  • Expected expiration: February 22nd in 2018
  • Creation date: February 21st in 1994
  • Renew date: February 18th in 2017
Bipolar Disorder Medication | SEROQUEL XR® (quetiapine fumarate)
http://pageoverview.com/website-report/seroquelxr.com
Find information to better understand major depressive disorder (MDD), bipolar disorder, bipolar depression, and SEROQUEL XR® (quetiapine fumarate).
  • Expected expiration: March 29th in 2018
  • Creation date: March 29th in 2007
  • Renew date: March 25th in 2017
Recipes, Activities, Treatment and Support for your Health Conditions
http://pageoverview.com/website-report/fit2me.com
Fit2Me™ a FREE food and activity program that's custom fit to you and your health challenges. Plus, there's personalized treatment information and support!
  • Expected expiration: August 15th in 2017
  • Creation date: August 15th in 2011
  • Renew date: August 11th in 2016
AZ Immuno-Oncology: Our Vision in Immuno-Oncology
http://pageoverview.com/website-report/azimmuno-oncology.com
Find out more about PD-L1 inhibition, CTLA-4 inhibition, other Immuno-Oncology pathways like OX40 agonism, Anti-CEA BiTE, STAT3 inhibition, and PD-1 inhibition.
  • Expected expiration: June 25th in 2020
  • Creation date: June 25th in 2015
  • Renew date: January 29th in 2016
Treatment for Asthma in Children | PULMICORT RESPULES® (budesonide inhalation suspension)
http://pageoverview.com/website-report/pulmicortrespules.com
  • Expected expiration: February 28th in 2018
  • Creation date: February 28th in 1999
  • Renew date: February 24th in 2017
Official Site: OMNARIS® (ciclesonide) Nasal Spray
http://pageoverview.com/website-report/omnaris.com
OFFICIAL SITE: OMNARIS® (ciclesonide) Nasal Spray. Details and information.
  • Expected expiration: August 17th in 2017
  • Creation date: August 17th in 2006
  • Renew date: May 3rd in 2016
Nexium Control – Per il bruciore di stomaco frequente
http://pageoverview.com/website-report/nexiumcontrol.it
Se soffri di bruciore di stomaco e reflusso gastrico Nexium Control è il medicinale a base di esomeprazolo ideale per il trattamento di pirosi e dispepsia.
  • Expected expiration: August 9th in 2017
  • Creation date: August 9th in 2013
  • Renew date: August 25th in 2016
Acid Reflux Medication | NEXIUM® (esomeprazole magnesium)
http://pageoverview.com/website-report/purplepill.com
Discover NEXIUM, the Purple Pill, which offers 24-hour heartburn relief caused by acid reflux disease. Ask your doctor if NEXIUM may be right for you.
  • Expected expiration: October 29th in 2017
  • Creation date: October 29th in 1999
  • Renew date: October 25th in 2016
Asthma Treatment | PULMICORT FLEXHALER® (budesonide inhalation powder, 90 mcg & 180 mcg)
http://pageoverview.com/website-report/pulmicortflexhaler.com
Official patient site. Learn about PULMICORT FLEXHALER a medication for the maintenance treatment of asthma symptoms in adults and children 6 years or older. Find information about the inhaler and side effects and a How to Use FLEXHALER video.
  • Expected expiration: November 16th in 2017
  • Creation date: November 16th in 2006
  • Renew date: November 12th in 2016
MOVANTIK® (naloxegol) | Opioid Induced Constipation Treatment
http://pageoverview.com/website-report/movantik.com
Official Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
  • Expected expiration: September 25th in 2017
  • Creation date: September 25th in 2013
  • Renew date: September 20th in 2016
TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) | HCP Site
http://pageoverview.com/website-report/tudorzahcp.com
Healthcare professional information on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with COPD.
  • Expected expiration: May 10th in 2020
  • Creation date: May 10th in 2012
  • Renew date: March 24th in 2016
PULMICORT FLEXHALER® (budesonide inhalation powder, 90 mcg & 180 mcg)
http://pageoverview.com/website-report/pulmicortflexhalertouchpoints.com
Official health care professional website for PULMICORT FLEXHALER® (budesonide inhalation powder, 90 mcg & 180 mcg), a maintenance asthma treatment for patients 6 years of age and older.
  • Expected expiration: October 15th in 2017
  • Creation date: October 15th in 2009
  • Renew date: October 11th in 2016
AstraZeneca Canada
http://pageoverview.com/website-report/astrazeneca.ca
  • Expected expiration: April 2nd in 2018
  • Creation date: October 9th in 2000
  • Renew date: March 19th in 2017
AstraZeneca Italy
http://pageoverview.com/website-report/astrazeneca.it
  • Expected expiration: March 28th in 2018
  • Creation date: February 9th in 2000
  • Renew date: April 13th in 2017
Heartburn Relief from Frequent Heartburn | Prilosec OTC
http://pageoverview.com/website-report/prilosecotc.com
Find out why Prilosec is the #1 doctor recommended medicine for frequent heartburn. Goodbye heartburn, hello relief.
  • Expected expiration: June 4th in 2017
  • Creation date: June 4th in 2002
  • Renew date: May 31st in 2016
  • Google Analytics: 2283429-1
MOVANTIK® (naloxegol) | Mu-Opioid Receptor Antagonist
http://pageoverview.com/website-report/movantikhcp.com
Official health care professional Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
  • Expected expiration: February 14th in 2019
  • Creation date: February 14th in 2014
  • Renew date: January 29th in 2016
Asthma research and Symbicort SMART
http://pageoverview.com/website-report/symbicort.com
Symbicort SMART delivered via the Symbicort Turbuhaler delivers medication to maintain asthma control and treat symptoms
  • Expected expiration: February 8th in 2018
  • Creation date: February 8th in 1999
  • Renew date: February 4th in 2017
astrazeneca-annualreports.com
http://pageoverview.com/website-report/astrazeneca-annualreports.com
  • Expected expiration: October 30th in 2017
  • Creation date: October 30th in 2007
  • Renew date: October 26th in 2016
AstraZeneca Portugal
http://pageoverview.com/website-report/astrazeneca.pt
    aza-lite.com
    http://pageoverview.com/website-report/aza-lite.com
    • Expected expiration: March 5th in 2018
    • Creation date: March 5th in 2007
    • Renew date: March 1st in 2017
    faslodextouchpoints.com
    http://pageoverview.com/website-report/faslodextouchpoints.com
    • Expected expiration: October 15th in 2017
    • Creation date: October 15th in 2009
    • Renew date: October 11th in 2016
    Symbicort® Turbuhaler®
    http://pageoverview.com/website-report/turbohaler.it
    • Expected expiration: November 5th in 2018
    • Creation date: November 5th in 2015
    • Renew date: November 21st in 2017
    Спeциализиран интернет сайт за лекари на AstraZeneca
    http://pageoverview.com/website-report/azcontact.bg
    Водещи специалисти по актуални теми, Новости в областта на медицината, Обучителни материали за пациента в помощ на лекаря
    • Google Analytics: 57635363-1
    Electrolux | Inicio
    http://pageoverview.com/website-report/electrolux.com.ec
    • Creation date: April 7th in 1999
    • Expected expiration: April 6th in 2018
    • Google Analytics: 52177496-1
    肺がんとともに生きる | アストラゼネカ
    http://pageoverview.com/website-report/haigan-tomoni.jp
    「肺がんとともに生きる」は、肺がんではないかと心配な方、肺がんと向き合う方やそのご家族の方などを対象としております。肺がんとともに生きるすべての方にお役立ていただける情報の提供を目指します。
    • Expected expiration: October 31st in 2018
    • Creation date: October 7th in 2015
    • Renew date: November 1st in 2017
    azhealth.hk
    http://pageoverview.com/website-report/azhealth.hk
    • Expected expiration: February 1st in 2019
    AstraZeneca Medicines | Product information for healthcare professionals
    http://pageoverview.com/website-report/simply4doctors.co.uk
    FOR HEALTHCARE PROFESSIONALS ONLY - The AstraZeneca Medicines portal provides information on AstraZeneca products.
    • Expected expiration: May 15th in 2018
    • Creation date: May 15th in 2007
    • Renew date: May 11th in 2017
    AstraZeneca US
    http://pageoverview.com/website-report/astrazeneca-us.com
    • Expected expiration: December 9th in 2017
    • Creation date: December 10th in 1998
    • Renew date: December 5th in 2016
    Lavitacon il cancro al polmone: le esperienze dei pazienti
    http://pageoverview.com/website-report/lavitacon.it
    Siamo accomunati dalla malattia. Le storie di chi, come noi, ha il cancro al polmone ci sostengono nel nostro percorso. Segui una community di persone come te.
    • Expected expiration: November 16th in 2018
    • Creation date: November 16th in 2016
    • Renew date: December 2nd in 2017
    Welcome to Alvesco | Alvesco.com
    http://pageoverview.com/website-report/alvesco.com
    • Expected expiration: April 10th in 2018
    • Creation date: April 10th in 2001
    • Renew date: April 6th in 2017
    • Google Analytics: 13105156-4
    Welcome to AstraZeneca AZ&Me | AZ&Me™ Prescription Savings Program
    http://pageoverview.com/website-report/azandmeapp.com
    The AZandMe Prescription Savings program is designed to help qualifying patients, including those who receive their medications through participating healthcare facilities. This site will guide you through the AZ&Me application process to see if you are eligible for the program. Find out if you qualify to receive AstraZeneca medicines at no cost.
    • Expected expiration: October 20th in 2017
    • Creation date: October 20th in 2009
    • Renew date: October 16th in 2016
    フォシーガ.jp
    http://pageoverview.com/website-report/forxiga.jp
    選択的SGLT2阻害剤-2型糖尿病治療剤-の「フォシーガ(forxiga)」のサイト、フォシーガ.jpへようこそ 「フォシーガ.jp」では、フォシーガの製品情報や糖尿病治療に関する様々な情報をお届けします。
    • Expected expiration: October 31st in 2017
    • Creation date: October 29th in 2011
    • Renew date: November 1st in 2016
    AstraZeneca France
    http://pageoverview.com/website-report/astrazeneca.fr
    • Expected expiration: April 5th in 2018
    • Creation date: October 23rd in 2008
    • Renew date: April 1st in 2017
    0.0562 // 2024-05-06 07:27:48
    All Rights reserved 2018 © PageOverview.com